- Welltower (WELL) is a $135 billion REIT focused on senior housing, healthcare, and outpatient facilities.
- Shares have strong technical momentum and are trading at a new all-time high.
- WELL stock is up 45% in the past year and over 50% in the year to date.
- Analyst sentiment is mostly positive, with multiple “Buy” ratings and price targets up to $246.
Today’s Featured Stock
Valued at $135 billion, Welltower (WELL) is a real estate investment trust (REIT) that is engaged in investments with senior housing operators, post-acute care providers, and health systems. Its portfolio is concentrated in major, high-growth markets in the United States, Canada and the U.K.
In addition to this, the company also offers a vast range of property management and development services. Welltower’s consolidated portfolio can be categorized into three operating segments: triple-net, senior housing opportunities, and outpatient medical facilities.
What I’m Watching
I found today’s Chart of the Day by using Barchart’s powerful screening functions to sort for stocks with the highest technical buy signals; superior current momentum in both strength and direction; and a Trend Seeker “buy” signal. I then used Barchart’s Flipcharts feature to review the charts for consistent price appreciation. WELL checks those boxes. Since the Trend Seeker signaled a new “Buy” on Oct. 17, the stock has gained 13.35%.
Barchart Technical Indicators for Welltower
Editor’s Note: The technical indicators below are updated live during the session every 20 minutes and can therefore change each day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report. These technical indicators form the Barchart Opinion on a particular stock.
Welltower hit an all-time high of $199.11 in morning trading on Nov. 18.
- WELL has a Weighted Alpha of +52.67.
- Welltower has a 100% “Buy” opinion from Barchart.
- The stock gained 45.07% over the past year.
- WELL has its Trend Seeker “Buy” signal intact.
- The stock recently traded at $199.02 with a 50-day moving average of $177.11.
- Welltower has made 12 new highs and gained 13.52% in the last month.
- Relative Strength Index (RSI) is at 79.53.
- There’s a technical support level around $195.18.
Don’t Forget the Fundamentals
- $135 billion market capitalization.
- 39.16x trailing price-earnings ratio
- 1.49% dividend yield.
- Revenue is projected to grow 30.44% this year and another 17.34% next year.
Analyst and Investor Sentiment on Welltower
I don’t buy stocks because everyone else is buying, but I do realize that if major firms and investors are dumping stock, it’s hard to make money swimming against the tide.
It looks like Wall Street and individual investors like this stock.
- The Wall Street analysts tracked by Barchart have issued 16 “Strong Buys,” 2 “Moderate Buys,” and 2 “Hold,” opinions on the stock with price targets between $162 and $246.
- Value Line rates the stock “Below Average” but has a price target of $214.
- CFRA’s MarketScope Advisor rates it a “Buy” with a price target of $210.
- Morningstar thinks with the stock’s recent runup, it’s 12% overvalued.
- 1,240 investors following the stock on Motley Fool think it will beat the market while 118 think it won't.
- 44,930 investors monitor the stock on Seeking Alpha, which rates the stock a “Hold.”
The Bottom Line on Welltower
With very high financial strength and a secure dividend, long-term investors might want to put this on a dividend reinvestment (DRIP) plan.
Today’s Chart of the Day was written by Jim Van Meerten. Read previous editions of the daily newsletter here.
Additional disclosure: The Barchart of the Day highlights stocks that are experiencing exceptional current price appreciation. They are not intended to be buy recommendations as these stocks are extremely volatile and speculative. Should you decide to add one of these stocks to your investment portfolio it is highly suggested you follow a predetermined diversification and moving stop loss discipline that is consistent with your personal investment risk tolerance.
On the date of publication, Jim Van Meerten did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart